AGM/EGMAug 7, 2026, 05:21 PM
Pasithea Therapeutics to Hold Annual Meeting; Proposes Reverse Split
AI Summary
Pasithea Therapeutics Corp. announced its Annual Meeting of Stockholders to be held virtually on September 9, 2026. Key proposals include the election of two Class III directors, ratification of CBIZ CPAs P.C. as the independent auditor, and approval of a reverse stock split. The proposed reverse split ratio can range from 1:2 to 1:20, with the final ratio to be determined by the Board.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on September 9, 2026, at 9:00 AM Eastern Time.
- Stockholders of record as of July 24, 2026, are entitled to vote.
- Proposing election of Dr. Tiago Reis Marques and Prof. Lawrence Steinman as Class III directors until 2029.
- Seeking ratification of CBIZ CPAs P.C. as independent auditor for fiscal year ending December 31, 2026.
- Proposing a reverse stock split with a ratio ranging from one-for-two (1:2) to one-for-twenty (1:20).
- The exact reverse split ratio will be determined by the Board without further stockholder approval.
Price Impact
More from KTTA